Article Text

Download PDFPDF
PTH-100 The effect of gastric helicobacter pylori infection on the intestinal microbiome of ibd patients
  1. N Quraishi1,
  2. N Bhala2,
  3. R Cooney2,
  4. S Pathmakanthan2,
  5. J McNamara3,
  6. S Gosh4,
  7. I Henderson5,
  8. T Iqbal1,
  9. A Rossiter5
  1. 1Institute of Cancer and Genomic Sciences, University of Birmingham
  2. 2Department of Gastroenterology, University Hospitals Birmingham
  3. 3College of Medical and Dental Sciences
  4. 4Institute of Translational Medicine
  5. 5Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK


Introduction Helicobacter pylori is a Gram-negative bacterium, which infects over 50% of the population worldwide. However, only a subset of these infections result in gastrointestinal diseases, such as peptic ulceration (10%) and gastric cancer (2%). Several epidemiological studies have revealed that people who carry H. pylori are at a decreased risk of developing IBD. However, a mechanistic understanding of the association between H. pylori infection and IBD is still unknown. Unlike any other microbial species, once H. pylori colonises its gastric niche, it is able to dominate the gastric microbiome, representing 90%–95% of the total microbial population. Therefore, we hypothesised that the presence of H. pylori in the upper gastrointestinal (GI) tract prevents the colonisation of the lower GI tract with microbial species associated with the pathogenesis of IBD.

Method To test this, we collected stool samples from IBD patients (comprising Ulcerative Colitis and Crohn’s disease patients) and determined their H. pylori status using a stool antigen test. We then characterised the intestinal microbiota of H. pylori positive (n=9) and negative IBD patients (n=18), by amplifying the V4 hyper-variable region of the 16S rRNA gene from faecal DNA. To determine the predominant phyla, these products were sequenced using the Illumina MiSeq and data analysis was performed using the QIIME pipeline and GreenGenes database.

Results Interestingly, bacterial community structure revealed that there is a strong trend towards a decrease of Proteobacteria and an increase of Bacteroidetes in H. pylori positive IBD patients. Of note, IBD is generally characterised by an increase in Proteobacteria and a decrease in Bacteroidetes. Furthermore, using PICRUSt to investigate the functional composition of the metagenomes, we found that the H. pylori positive IBD patients displayed significant functional differences, including decreased bacterial motility and chemotaxis (p=<0.05), demonstrating suppression of virulence traits.

Conclusion Our preliminary data suggests that the presence of H. pylori infection may promote a less pathogenic intestinal microbiome in patients with established IBD. This data provides the rationale to extend our studies with increased patient numbers and healthy controls to determine the mechanistic basis for the negative association of H. pylori infection and IBD.

Disclosure of Interest None Declared

  • Helicobacter pylori
  • Inflammatory Bowel Disease
  • Microbiome

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.